TAVR vs. Redo Open Heart Surgery for Aortic Valve Stenosis: How to Choose the Right One for You

“If someone has already had their aortic valve replaced and they've now developed dysfunction of that prosthetic valve, we often have to make a decision between TAVR and redo [open heart] surgery,” says Mackram F. Eleid, MD, an interventional cardiologist with Mayo Clinic.
Whether transcatheter aortic valve replacement (TAVR) or redo surgical aortic valve replacement (SAVR, an open heart surgery) is right for you is an important decision you have to make with your care team. These two treatment paths carry their own risks and benefits that should be carefully weighed.
What Are TAVR and SAVR?
The redo SAVR procedure is more invasive and involves the surgical team opening your chest. “They take the old valve out, whether that's an old surgical valve or old transcatheter valve, and put a new one in,” says Gilbert Hin-Lung Tang, MD, the surgical director of the Structural Heart Program at the Mount Sinai Health System in New York City. “About a third of the time, the surgeon needs to do additional procedures to either repair or replace another valve, or do coronary bypass or other reconstructive work.”
With TAVR, often called a valve-in-valve procedure, the surgeon will leave the old failing valve in place. Rather than open the chest, they will create a pinkie-size cut in your groin to access a major artery, Dr. Tang says. They’ll then thread a long, flexible tube called a catheter to your aortic valve and use the device to deploy a new valve directly inside the old valve.
Weighing the Clinical Risks
Choosing between TAVR and redo SAVR ultimately comes down to weighing the procedures’ various risks and benefits, many of which shift depending on factors like your age, health, and how long you’ll need the replacement valve.
Survival Rates
Research comparing these two procedures is limited, making it challenging to draw concrete conclusions or collect survival statistics.
Patients who undergo redo SAVR are typically the lower-risk patients who don't have any prior open-heart surgery or other major illnesses, Dr. Eleid says.
Complication Risks
There are some notable similarities and differences between TAVR and SAVR when it comes to risk of complications.
Recovery
One of the biggest benefits of TAVR over SAVR is recovery time.
“For [open] surgery, the first 24 hours are typically in the intensive care unit, depending on how complex the surgery is,” Tang says. “For TAVR, most patients, unless there's a complication, go straight to the regularly monitored floor and get discharged once they're medically ready.”
This also means that people who undergo TAVR are able to get up and move around a lot sooner. They usually have to rest in bed for several hours to allow the artery in the leg to heal, Eleid says. “Patients are usually walking in the afternoon or evening that same day,” he notes.
Pacemakers
Both TAVR and SAVR carry risks for needing a permanent pacemaker implantation.
“When we're fixing the aortic valve with any technique, we can injure the wiring of the heart because the conduction system, the electrical system of our heart, runs right by the aortic valve,” Eleid says.
Valve Longevity
It’s important to consider how long your replacement valve will last, especially if you’re a younger patient who may have it for years to come.
“Surgical valves last quite some time, especially the current generation, which tends to last 10 or more years,” Tang says. “For TAVR, we now have up to 7-year data that looks very good … but beyond that we're not sure yet.”
How to Choose the Right Procedure for You
- Older patients typically get TAVR because of the risks of open heart surgery.
- Greater frailty increases risks associated with surgery.
- Life expectancy: Surgical valves may last longer, which is a consideration if you have greater life expectancy.
- Other health conditions: People with conditions such as coronary artery disease may need to be treated simultaneously through open heart surgery.
- You’ll need open heart surgery if the valve size does not fit your body.
- Initial replacement procedure: Scar tissue from open heart surgery can make redo surgery especially risky.
- Tolerance for anticoagulation medications. Blood thinners may be needed if you develop blood clots from TAVR-related paravalvular leakage.
Resources We Trust
- Mayo Clinic: TAVR or SAVR: Which aortic valve replacement is right for me?
- Cleveland Clinic: Valve-in-Valve TAVR vs. Redo SAVR for a Failed SAVR Bioprosthesis
- American Heart Association: What Is TAVR? (TAVI)
- National Institutes of Health: Procedure makes heart valve replacement safer for high-risk patients
- American College of Cardiology: CMS Proposes Updates to TAVR National Coverage Determination
- Aortic Valve Stenosis Diagnosis and Treatment. Mayo Clinic. May 10, 2025.
- Transcatheter Aortic Valve Replacement (TAVR). Mayo Clinic. April 12, 2025.
- Aortic Valve Surgery. Cleveland Clinic. November 27, 2024.
- Tran JH et al. Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves. JAMA Cardiology. May 22, 2024.
- Formica F et al. Redo Surgical Aortic Valve Replacement versus Valve-In-Valve Transcatheter Aortic Valve Implantation: A Systematic Review and Reconstructed Time-To-Event Meta-Analysis. Journal of Clinical Medicine. January 9, 2023.
- Goel SS et al. TAV-in-SAV or Redo SAVR: Are We Comparing Apples With Oranges? American Journal of Cardiology. March 15, 2024.
- Tran JH et al. Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves. JAMA Cardiology. May 22, 2024.
- Dimitriadis KS et al. Valve in valve transcatheter versus redo surgical replacement of a failing surgical bioprosthetic aortic valve: An updated systematic review and meta-analysis. Journal of Cardiology. November 2025.
- Awtry J et al. TAVR vs. SAVR: Understanding Your Aortic Valve Treatment Options. University of Utah Health. November 6, 2023.
- Sharaf OM et al. Aortic valve 2024: Which valve for which patient? Journal of Thoracic and Cardiovascular Surgery. July 2025.
- Tang GH et al. Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry. JACC: Cardiovascular Interventions. April 24, 2023.

Cheng-Han Chen, MD, PhD, FACC, FSCAI
Medical Reviewer
Cheng-Han Chen, MD, PhD, is the medical director of the structural heart program at MemorialCare Saddleback Medical Center in Laguna Hills, California, and director of structural a...

Joseph Bennington-Castro
Author
Joseph Bennington-Castro is a science writer based in Hawaii. He has written well over a thousand articles for the general public on a wide range topics, including health, astronom...